[ISOMORPHICLABS]score: 0.28
Isomorphic Labs closes $2.1B Series B for drug discovery AI
May 13, 2026
Isomorphic Labs closed a $2.1B Series B for its IsoDDE drug discovery platform, backed by Thrive Capital and sovereign funds, with active partnerships at Novartis, Lilly, and J&J moving toward clinical trials.